Skip to main content

Table 2 Univariate survival analysis of biochemical recurrence (BCR)-free survival in 128 patients with PCa

From: Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

Variables

BCR-free survival

Exp (B)

95% CI

P

Age (<70 vs. ≥70)

2.68

0.17–5.03

NS

Preoperative PSA (<10 ng/mL vs. ≥10 ng/mL)

2.34

0.11–4.48

NS

Gleason score (4–6 vs. 7–10)

2.26

0.10–4.32

NS

Pathological stage (T1-2 vs. T3-4)

5.61

1.12–11.28

<0.001

Lymph node metastasis (Negative vs. Positive)

4.13

0.82–8.22

0.002

Angiolymphatic invasion (Negative vs. Positive)

5.62

1.12–11.39

<0.001

Surgical margin status (Negative vs. Positive)

2.27

0.10–4.82

NS

miR-126 expression (High vs. Low)

5.68

1.19–11.33

<0.001

  1. Note: ‘NS’ refers to the difference without statistic significance.